Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C031903 |
1-UFT protocol |
LAMP2 protein results in decreased susceptibility to 1-UFT protocol | decreases response to substance | 16734730
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of LAMP2 mRNA | increases expression | 18648102
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of LAMP2 mRNA | affects expression | 16483693
|
D016718 |
Arachidonic Acid |
Arachidonic Acid results in decreased expression of LAMP2 mRNA | decreases expression | 16623957
|
D001149 |
Arsenates |
[Atrazine co-treated with Arsenates] results in increased expression of LAMP2 mRNA | affects cotreatment|increases expression | 18585445
|
D001280 |
Atrazine |
[Atrazine co-treated with Arsenates] results in increased expression of LAMP2 mRNA | affects cotreatment|increases expression | 18585445
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LAMP2 mRNA | decreases expression | 20018196
|
C053541 |
bicalutamide |
bicalutamide results in increased expression of LAMP2 mRNA | increases expression | 16631469
|
C472777 |
bisperoxovanadium |
bisperoxovanadium results in increased expression of LAMP2 protein | increases expression | 17601985
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LAMP2 mRNA | affects cotreatment|affects expression | 17602206
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LAMP2 mRNA | affects cotreatment|affects expression | 17602206
|
D004958 |
Estradiol |
Estradiol affects the expression of LAMP2 mRNA | affects expression | 15598610
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of LAMP2 mRNA | affects expression | 17555576
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of LAMP2 mRNA | increases expression | 17616710
|
D017239 |
Paclitaxel |
LAMP2 protein affects the susceptibility to Paclitaxel | affects response to substance | 16217747
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of LAMP2 mRNA | affects expression | 17555576
|
D013876 |
Thiophenes |
Thiophenes analog promotes the reaction [Tretinoin results in increased expression of LAMP2 mRNA] | increases expression|increases reaction | 16140955
|
D014212 |
Tretinoin |
Thiophenes analog promotes the reaction [Tretinoin results in increased expression of LAMP2 mRNA] | increases expression|increases reaction | 16140955
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of LAMP2 mRNA | increases expression | 16140955 16249480
|
D014501 |
Uranium |
Uranium affects the expression of LAMP2 mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of LAMP2 mRNA | affects expression | 15672453
|
D002762 |
Cholecalciferol |
Cholecalciferol results in increased expression of LAMP2 mRNA | increases expression | 16508948
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.44 | 14745880 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.45 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.84 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.13 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.13 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.46 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.46 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
3.79 | 17620307 16434500 18056438 19052882 17162532 19061943 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
4.12 | 11874814 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.53 | 15955085 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.36 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.98 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.98 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.31 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
3.04 | 18582451 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
4.92 | 16142846 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.29 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.91 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.51 | 16206674 16197459 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.46 | 15867366 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.31 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.31 | 17289903 19861407 12948864 17261762 14630087 18497071 17018787 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.31 | 18223236 18323546 18234424 15136595 11325840 16273361 16115903 16244791 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.31 | 19410462 19155303 20390343 15668708 19244106 18629630 19288272 19084267 18997820 20135344 18821012 19115204 20859285 19221464 19289846 20544844 17440819 17893378 16818667 18815881 17049068 19189210 19487384 15565566 21152245 11161223 19066611 19103187 17242785 16202921 16873071 19189212 18425577 19011961 18984771 18855134 17261762 18351453 20005174 19142967 19200415 19059307 20065188 16273361 21138602 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.31 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.48 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.35 | 16111702 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.40 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.05 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
11.17 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
11.17 | 17138121 19519916 16569478 16540662 19171122 18494052 16698587 21159647 17055752 20935162 20214788 3581430 20514400 19335982 20727157 19418558 10672840 18665156 17173139 16807293 16288022 19822196 16935385 19107877 16328049 16681979 16502159 20432363 16878318 20007298 18506893 18393292 19919837 20084675 19208518 20101231 17761372 19394651 18788625 18056438 17978847 18785209 19539802 16830150 19701751 11831363 19052882 17162532 18210153 18978308 3084413 18971187 19383236 18691550 10737359 16779866 20524982 17428255 20512989 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
11.17 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
11.17 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
11.17 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
11.17 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.62 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.26 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.52 | 17572228 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.03 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
15.39 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
15.39 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
15.39 | 17174075 21159647 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
15.39 | 18566989 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.48 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.59 | 19052882 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.59 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.59 | 11677210 17333356 17110522 16105132 15861022 16919318 17681005 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.05 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.62 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.60 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
2.44 | 18802399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.81 | 8800419 17551590 9664655 16925845 14991402 10589399 9211117 9224671 9142499 9125849 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.25 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.70 | 8156756 2524372 12868966 8970840 18759878 11298694 11906362 14531868 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.39 | 2952479 3621924 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.16 | 20387270 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.52 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.52 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
3.78 | 6679447 9328219 18692083 6482804 18289764 1440618 9022650 7440962 18648102 16192314 11289319 8291058 9653073 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.78 | 19107877 |
MESH:D004487 |
Edema |
|
Arachidonic Acid |
3.94 | 16716910 9831321 15177302 7990266 11698051 9599246 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.36 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.59 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.59 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.01 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
12.01 | 17893378 20544844 19155303 16202921 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.01 | 16569247 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.01 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.21 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.21 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
10.21 | 16510608 15547721 15878914 16704527 15623463 15150132 15264214 16805852 15547733 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
10.21 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.49 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
12.51 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.51 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
12.51 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.17 | 16709447 |
MESH:D005334 |
Fever |
|
Arachidonic Acid |
4.56 | 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.91 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.42 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.07 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.41 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.93 | 17312396 |
MESH:D052120 |
Glycogen Storage Disease Type IIb |
marker/mechanism |
|
| |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.93 | 7505956 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.11 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.05 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.84 | 14991402 9664655 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.41 | 6705139 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.93 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.65 | 17088409 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.12 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.46 | 16778211 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.83 | 15034207 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.70 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.36 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
6.66 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.66 | 17937319 |
MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
8.16 | 15177302 17371808 9831321 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.16 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.16 | 19457130 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.89 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.66 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.91 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.80 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.52 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.88 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.88 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.88 | 18625569 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.72 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.60 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.06 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Thiophenes |
7.99 | 16140954 16140955 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.99 | 17217047 16788101 17368321 17649720 19225113 16891316 19029980 17361223 17301526 16823087 16766008 9834237 16140955 17712046 16331271 19642359 15748426 17107899 17506722 19035177 12679006 17339181 16935935 17294898 19075265 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.23 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.08 | 17567588 15342952 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.72 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.76 | 18522880 18407596 20032147 19638242 18665156 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.13 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.43 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.43 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.43 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.07 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
7.28 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
7.28 | 20101389 20501860 19690152 10737359 20583210 19256749 20452335 18978307 19638242 19833225 19254457 21167192 19294768 19642983 20137499 20434301 12771043 20118626 19499222 19090486 18648771 19551842 19812893 2422723 21278145 20492335 18977376 15885732 15175105 20405173 12112319 18644402 19426721 2862719 18754104 21047994 19996281 19850985 19427195 19073162 19255062 16942905 9163691 21071580 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.28 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
5.69 | 3712494 598648 1399818 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
5.69 | 18308698 18775883 16842330 19539802 18093689 18544905 17854601 16267830 2563599 19009564 18253720 18079962 9362446 18164116 21159647 17174075 19126423 18282651 19004024 17942915 19519916 3124819 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.41 | 21163286 20970405 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.41 | 18625569 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
4.00 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.65 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.73 | 16891317 11807958 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.73 | 16827153 11731420 19196723 14580682 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.29 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.29 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.74 | 17453147 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
5.06 | 12025231 12040289 16342250 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.06 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.06 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.07 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.32 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.48 | 1916698 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.61 | 14749477 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.02 | 17596541 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.19 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
13.24 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
13.24 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
13.24 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
13.24 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.48 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.36 | 16946489 16594593 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.89 | 19200415 19189210 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.62 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.31 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.31 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.99 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.99 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.25 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.01 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.32 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.91 | 3988306 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.87 | 15867366 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.75 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
7.75 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.75 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.81 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.12 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.12 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.58 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.38 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
3.23 | 17218051 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.36 | 6228378 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.46 | 2563599 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.78 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
1.91 | 18487222 19240160 19011039 15638997 17914592 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
1.91 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.91 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
1.91 | 17172428 16356831 16729912 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.91 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.50 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.20 | 16919318 15861022 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.68 | 16723453 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
4.41 | 11874814 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.29 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.99 | 16116481 16283617 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.56 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.21 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.21 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.93 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.68 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
4.68 | 17575124 12958204 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
4.68 | 18396642 18506536 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.68 | 17261132 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.70 | 16930453 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.52 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.06 | 15669648 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.46 | 6582329 7505956 6587162 1399818 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
11.46 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.46 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.58 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.69 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.16 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.89 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
4.89 | 17572228 16712894 8653321 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.58 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.19 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.50 | 16752155 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.44 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.95 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.87 | 16287080 |